NewAmsterdam Pharma Company
NAMS • NASDAQ
NewAmsterdam Pharma Company is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael Harvey Davidson Facp., with a market cap of $3.8B.
CEOMichael Harvey Davidson Facp.
Market Cap$3.8B
Biotechnology
Healthcare
Employees29.0
Websitenewamsterdampharma.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for NewAmsterdam Pharma Company
Date
Thursday, May 7, 2026 (in 2 months)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.44
Revenue Estimate
$1.5M
Earnings History
Past 6 earnings reports for NewAmsterdam Pharma Company
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Q4 2025 | -$0.63Est: -$0.38 | -65.8% | $32.0KEst: $4.3M | -99.3% |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.61Est: -$0.36 | -69.4% | $348.0KEst: $4.3M | -91.9% | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.15Est: -$0.46 | +67.4% | $19.1MEst: $2.2M | +756.6% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.34Est: -$0.44 | +22.7% | $3.0MEst: $1.5M | +104.0% | 10-Q |
| Feb 26, 2025 | Q4 2024 | -$0.51 | — | $8.6M | — | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.18 | — | $29.1M | — | 10-Q |